Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Advanced Micro Devices Inc N.AMD


Primary Symbol: AMD

Advanced Micro Devices, Inc. is a global semiconductor company. The Company is focused on high-performance computing, graphics and visualization technologies. Its segments include Data Center, Client, Gaming and Embedded. The Data Center segment includes server central processing unit (CPUs), graphics processing units (GPUs), accelerated processing units (APUs), data processing units (DPUs... see more

Bullboard (NDAQ:AMD)

View:
Post by long342on Feb 09, 2022 12:17pm

AMD increases server interest at expense of INTEL

INTEL loosing control of world  server business to AMD .....bigtime
Post by long342on Feb 08, 2022 1:30pm

AMD GROWTH STORY REMAINS THE SAME

AND FORCASTS RECORD. EARNINGS IN Q1(FIRST  QTR OF 2022)
Post by long342on Feb 08, 2022 1:26pm

AMD a screaming buy

and could hit $200 in 2022..     Maybe even higher with NVDIA DEALS.
Post by long342on Feb 08, 2022 10:32am

NVDIA and AMD in talks?

Something big is brewing. Thanks Dave and HAL.@
Post by long342on Feb 08, 2022 10:32am

NVDIA and AMD in talks?

Something big is brewing. Thanks Dave and HAL. 
Post by ScarletteBourneon Feb 04, 2022 2:17am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid ...more  
Post by long342on Feb 03, 2022 4:12pm

UBS raises AMD target to $150/share from $115/share

based on AMD 4th QTR and guidence for 2022.  Positive news will validate their target price  in the coming quarters no doubt.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities